Literature DB >> 6299947

Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

C Dahlgren, O Stendahl.   

Abstract

When polymorphonuclear leukocytes (PMNL) and soluble or particulate matter interact, the cells produce chemiluminescence, linked to activation of the oxidative metabolism of the cells. PMNL isolated from a patient with a myeloperoxidase deficiency were found to produce almost no luminol-dependent chemiluminescence, despite a pronounced production of superoxide anions (O2-). The chemotactic peptide formylmethionyl-leucyl-phenylalanine induced a two-peak chemiluminescence response in control PMNL. The response was modified, both in magnitude and in time-course, when the cells were incubated at 22 degrees C for 120 min. Addition of purified myeloperoxidase to the PMNL lacking this enzyme, before stimulus addition, resulted in a chemiluminescence response. In the response to formylmethionyl-leucyl-phenylalanine, only one peak, corresponding to the initial peak of control PMNL, was found. This indicated that luminol-dependent chemiluminescence is dependent on and directly related to the presence of myeloperoxidase in PMNL and that both intra- and extracellularly located myeloperoxidase has to be taken into account when interpreting the cellular response assayed as chemiluminescence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299947      PMCID: PMC348011          DOI: 10.1128/iai.39.2.736-741.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Autooxidation as a basis for altered function by polymorphonuclear leukocytes.

Authors:  R L Baehner; L A Boxer; J M Allen; J Davis
Journal:  Blood       Date:  1977-08       Impact factor: 22.113

2.  Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system.

Authors:  H J Cohen; M E Chovaniec
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

3.  Myeloperoxidase-mediated iodination in granulocytes.

Authors:  I Olsson; T Olofsson; H Odeberg
Journal:  Scand J Haematol       Date:  1972

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity.

Authors:  R C Allen; R L Stjernholm; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

6.  The origin of the chemiluminescence of phagocytosing granulocytes.

Authors:  B D Cheson; R L Christensen; R Sperling; B E Kohler; B M Babior
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

7.  Effect of chemoattractants on chemiluminescence.

Authors:  C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase.

Authors:  L S Webb; B B Keele; R B Johnston
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

9.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  46 in total

1.  Polymorphonuclear leukocyte chemiluminescence induced by formylmethionyl-leucyl-phenylalanine and phorbol myristate acetate: effects of catalase and superoxide dismutase.

Authors:  C Dahlgren
Journal:  Agents Actions       Date:  1987-06

2.  Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus.

Authors:  M L Devalon; G R Elliott; W E Regelmann
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

3.  The influence of retinoic acid and retinoic acid derivatives on beta2 integrins and L-selectin expression in HL-60 cells in vitro.

Authors:  F Sjögren; O Stendahl; O Ljunghusen
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

4.  Phagocytosis by lipopolysaccharide-primed human neutrophils is associated with increased extracellular release of reactive oxygen metabolites.

Authors:  P Follin; C Dahlgren
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

5.  Interleukin-2 modulatory effects on the functional activity of human mononuclear cells in vitro.

Authors:  S V Shirshev; S A Zamorina; E G Orlova; V P Timganova
Journal:  Dokl Biol Sci       Date:  2009 Nov-Dec

6.  Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.

Authors:  M T Labro; C Babin-Chevaye
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

7.  Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.

Authors:  A Kharazmi; N Høiby; G Döring; N H Valerius
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

8.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  G Briheim; O Stendahl; C Dahlgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Luminol and diazoluminomelanin as indicators of HL-60 cell differentiation.

Authors:  J G Bruno; J L Kiel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

10.  Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Authors:  S Sedghi; J Z Fields; M Klamut; G Urban; M Durkin; D Winship; D Fretland; M Olyaee; A Keshavarzian
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.